Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Dec 8;11(1):17.
doi: 10.1186/s13722-016-0065-6.

Alcohol use in opioid agonist treatment

Seonaid Nolan  1   2 , Jan Klimas  3   4 , Evan Wood  3   5
Affiliations
Review

Alcohol use in opioid agonist treatment

Seonaid Nolan et al. Addict Sci Clin Pract. .

Abstract

Alcohol misuse among individuals receiving agonist treatment for an opioid use disorder is common and is associated with significant morbidity and mortality. At present, though substantial research highlights effective strategies for the screening, diagnosis and management of an alcohol or opioid use disorder individually, less is known about how best to care for those with a dual diagnosis especially since common treatments for opioid addiction may be contraindicated in a setting of alcohol use. This review summarizes existing research and characterizes the prevalence, clinical implications and management of alcohol misuse among individuals with opioid addiction. Furthermore, it highlights clinically relevant management strategies in need of future research to advance care for this unique, but important, patient population.

Keywords: Alcohol misuse; Alcohol use; Alcohol use disorder; Buprenorphine/naloxone; Methadone; Opioid agonist treatment.

PubMed Disclaimer

References

    1. Soyka M. Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment. Eur Addict Res. 2015;21(2):78–87. doi: 10.1159/000363232. - DOI - PubMed
    1. Degenhardt L, Hall W. Patterns of co-morbidity between alcohol use and other substance use in the Australian population. Drug Alcohol Rev. 2003;22(1):7–13. doi: 10.1080/0959523021000059776. - DOI - PubMed
    1. Potter JS, Marino EN, Hillhouse MP, Nielsen S, Wiest K, Canamar CP, et al. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START) J Stud Alcohol Drugs. 2013;74(4):605–613. doi: 10.15288/jsad.2013.74.605. - DOI - PMC - PubMed
    1. Rowan-Szal GA, Chatham LR, Simpson DD. Importance of identifying cocaine and alcohol dependent methadone clients. Am J Addict. 2000;9(1):38–50. doi: 10.1080/10550490050172218. - DOI - PubMed
    1. Gossop M, Marsden J, Stewart D, Rolfe A. Patterns of drinking and drinking outcomes among drug misusers. 1-Year follow-up results. J Subst Abuse Treat. 2000;19(1):45–50. doi: 10.1016/S0740-5472(99)00097-5. - DOI - PubMed

Substances